BioCentury
ARTICLE | Top Story

EUR100 million global fund

February 1, 2001 8:00 AM UTC

Brussels-based KBC Asset Management and KBC Securities announced plans to launch a new closed-end biotech fund of up to EUR100 million ($92 million) at EUR15 per share. KBC Private Equity Fund Biotech...